Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	ModNal	45
Overall Study	STARTED	Naltrexone and Placebo	40
Overall Study	STARTED	Modafinil and Placebo	37
Overall Study	STARTED	Double Placebo	42
Overall Study	COMPLETED	ModNal	28
Overall Study	COMPLETED	Naltrexone and Placebo	19
Overall Study	COMPLETED	Modafinil and Placebo	24
Overall Study	COMPLETED	Double Placebo	20
Overall Study	NOT COMPLETED	ModNal	17
Overall Study	NOT COMPLETED	Naltrexone and Placebo	21
Overall Study	NOT COMPLETED	Modafinil and Placebo	13
Overall Study	NOT COMPLETED	Double Placebo	22

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00142818/flow